StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report sent to investors on Thursday. The brokerage issued a hold rating on the software maker’s stock.
Veradigm Stock Down 0.1 %
Veradigm stock opened at $9.50 on Thursday. Veradigm has a twelve month low of $5.01 and a twelve month high of $11.80. The stock’s fifty day simple moving average is $9.98 and its 200-day simple moving average is $9.73.
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- Investing in Construction Stocks
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Best Stocks Under $10.00
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
